Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)

NCT02586350

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
View all 19 locations
View Trial Details
Completed

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

NCT02039947

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +16 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Aurora, Colorado, United States
  • Novartis Investigative Site Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Completed

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

NCT02027961

Conditions
Melanoma, Neoplasm Metastasis, Neoplasms, +14 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Miami Beach, Florida, United States
View Trial Details
Completed

E-MOSAIC Electronic Tool to Monitor Symptoms

NCT00477919

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +115 more
Locations
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Spital Buelach Bülach, Switzerland
View Trial Details
Completed

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01258855

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Completed

Phase I Study of BCD-145 (Anti-CTLA-4) in Patients With Unresectable/Metastatic Melanoma

NCT03472027

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • N.N. Blokhin National Medical Research Center of Oncology Moscow, Russia
  • JSC "Modern Medical Technologies" Saint Petersburg, Russia
  • N.N. Petrov National Medical Research Center of Oncology Saint Petersburg, Russia
  • Saint-Petersburg Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological) Saint Petersburg, Russia
View Trial Details

Related conditions